Linked In       FaceBook       Twitter       You Tube
Champ
Podio
Project management using Podio

 

MORE INFORMATION
Association for Molecular Pathology

AMP Position Statements and Letters - 2016

 

2016 Title Keywords Committee
December 22

AMP and CAP Joint Comments to CGS on Bladder Tumors

 

CGS, dLCD, MAC, CAP Economic Affairs
December 2

Comments to NGS on Genomic Sequence Analysis Panles in the Treatment of Acute Myelogenous Leukemia (DL36926)

 

NGS, GSP, AML, dLCD, MAC, CAP Economic Affairs
December 1

Comments to CGS on APC and MUTYH Gene Testing dLCD (DL36910)

 

CGS, MAC, CAP, dLCD Economic Affairs
December 1

Comments to Noridian on APC and MUTYH Gene Testing dLCD (DL36882)

 

Noridian, CAP, MAC, dCLD Economic Affairs

November 14

 

Comments to First Coast on dLCD on Noncovered Services (DL33777)

 

CMS, MAC, First Coast, HHV-6 Economic Affairs
October 31

Comments to CMS on CY2017 CLFS Preliminary Determinations

 

CMS, CLFS, GSP, CPT Economic Affairs

October 31

 

Reconsideration Request to CMS on Final Gapfill Determinations

 

CMS, GSP, CLFS, CPT Economic Affairs
October 14

Joint Letter to CDC Regarding Molecular Testing for Zika Virus

 

ASM, PASCV, Zika, CDC, rRT-PCR

 

Professional Relations
October 13

Comments to FDA on Principles for Codevelopment of an In Vitro Companion Diagnostic Device with a Therapeutic Product

 

IVD, FDA, Companion Dx Professional Relations
October 6

Comments to FDA on Use of Public Human Genetic Varient Databases to Support Clinical Validity for NGS-based IVDs

 

FDA, NGS, IVD, Database, Clinical Validity Professional Relations
October 6

Comments to FDA on Use of Standards in FDA Regulatory Oversight of NGS IVDs Used for Diagnosing Germline Diseases

 

FDA, NGS, IVD Professional Relations

October 6

 

Comments to FDA on Retrospective Review of PMA Application Devices

 

FDA, PMA, IVD Professional Relations
September 11 ASM, AMP, APHL, IDSA, and PASCV Comments to FDA on Next Generation Sequencing for Infectious Diseases

FDA, NGS, APHL, AMP, IDSA, PASCV

 

Professional Relations
August 12

AMP-CAP Comments to NGS on Molecular Pathology Procedures dLCD (DL35000)

 

CAP, dLCD, MAC Economic Affairs
August 10

Comments to CMS on 2016 Gapfill Preliminary Determinations

 

CMS, CLFS, CPT, GSP Economic Affairs
August 8

AMP-CAP Comments to Cahaba on BRCA1 and BRCA2 Genetic Testing (DL36741)

 

BRCA, CAP, Cahaba, dLCD, MAC

Economic Affairs
August 8

AMP-CAP Comments to Noridian on Bladder Tumor Markers dLCD (DL36678)

 

CAP, Noridian, dLCD, MAC

Economic Affairs

 

August 8

Comments to CMS on CY2017 CLFS

 

CMS, CLFS, CPT, GSP

 

Economic Affairs
August 2

Comments to FDA on E18 Genomic Sampling and Management of Genomic Data

 

FDA, IVD, IHC

Professional Relations

 

August 2

Letter of Support for S.2978 - Protect Continuing Physician Education and Patient Care Act

 

Education, CME Professional Relations
July 7

AMP-CAP Comments to Noivats on Biomarkers Overview dLCD - DL35062

 

CAP, Novitas, dLCD, MAC Economic Affairs
July 7

AMP-CAP Comments to Novitas on Biomarkers for Oncology- DL35396

 

CAP, Novitas, dLCD, MAC Economic Affairs

July 7

 

AMP-CAP Comments to Novitas on BRCA1 and BRCA2 Genetic Testing - DL36715

BRCA, CAP, Novitas, dLCD, MAC

 

Economic Affairs
June 3

Comments to FDA on Emergency Use Authorization of Medical Products and Related Authorities

 

EUA, IDSA, LDP, LDT, IVD Professional Relations
April 29

Comments to NYSDOH on Proposed Policy for Risk-based Evaluation of Laboratory Developed Tests

 

NYSDOH, LDP, LDT Professional Relations
April 15

AMP-CAP Comments to Cahaba on dLCD on K-RAS Testing Prior to Treatment of Colorectal Cancer

 

MAC, Cahaba, KRAS, CAP, dLCD Economic Affairs
April 4

AMP-CAP Comments to Noridian on MOLDX: Chromosome 1p/19q Deletion Analysis

 

MAC, Noridian, CAP, dLCD Economic Affairs
March 31 Comments to FDA on the Return of Genetic Test Results

FDA, Genetic Test Results

 

Professional Relations
March 28 Comments to FDA on NGS-Based Oncology Panels

FDA, NGS, Oncology, LDP

 

Professional Relations
February 19

Comments to CMS on Request for Information Regarding the Awarding and the Administration of MAC Contracts

 

CMS, MAC, LCD, gapfill Economic Affairs
January 28

Sign-on letter opposing EEOC GINA proposed rule

 

GINA, EEOC, Genetic Testing Professional Relations
January 6

AMP Comments on Common Rule NPRM

 

NPRM, ASIP, Biospecimens, Common Rule, HHS

 

Professional Relations